“…during rhEPO therapy and after bone marrow transplantation [5, 6]. While some authors have already described the diagnostic value of red cell distribution widths as indicators of iron depletion and of the intensity of erythropoietic activity in patients with anemia in rheumatoid arthritis, thalassemia, sickle cell anemia, as well as in alcoholics, malaria patients and patients with iron deficiency anemia there are practically no such studies on the reticulocyte distribution widths [7, 8, 9, 10, 11]. In a double-blind, randomized placebo-controlled trial on HBT avoidance by preoperative rhEPO therapy in cardiac surgery patients without ABD we therefore additionally examined the changes in distribution widths of red cells and reticulocytes during and after therapy with rhEPO (epoetin beta) and considered their diagnostic value in assessing iron status and the kinetics of erythropoiesis.…”